Special Issue "Emerging Nanocarriers-Based Drug Delivery in Inflammation-Associated Diseases"
Deadline for manuscript submissions: closed (31 October 2020).
Interests: Targeted drug delivery; Functionalized nanoparticles; Cytokines; Cardiovascular diseases; Inflammation; Endothelium; Monocytes/Macrophages; Natural and synthetic therapeutic agents
“Smart” targeted therapies based on nanocarriers are highly attractive because, in addition to the ability to deliver the needed drugs to the specific pathological place, they have the benefit of reducing drug concentration at non-target locations ensuing in fewer side effects.
This Special Issue focuses on nanocarriers developed as efficient drug delivery systems and will include papers describing the design, preparation and characterization of various nanocarriers-based drug delivery systems with tunable composition, architecture and functionalities and their use in the treatment of inflammation associated-diseases (cardiovascular diseases, cancer, diabetes, metabolic syndrome, auto-immune diseases, neurodegenerative diseases, etc.).
Authors are invited to submit original and review articles covering all the aspects of nanocarriers developed to mediate an effective drug delivery to specific pathological locations.
Dr. Manuela Calin
Manuscript Submission Information
Manuscripts should be submitted online at www.dlhwdz.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- targeted delivery
- surface functionalization
- cardiovascular diseases
- therapeutic agents
- RNA interference